Lifeboat Foundation

AstraZeneca said on Tuesday that it had asked the Food and Drug Administration to grant emergency authorization for an antibody treatment to prevent Covid-19 in people who are at high risk of the disease. If authorized, it would become the first such preventive treatment to be available in the United States, the company said.

The company said in a statement that the treatment had reduced the risk of symptomatic Covid-19 by 77 percent in a trial in which most participants either had other medical conditions that placed them at greater risk of severe illness or were not producing sufficient antibodies after vaccination.

It said the treatment could be used in conjunction with vaccines in people with weaker immune systems. Other antibody treatments in use in the United States, including one developed by the drug maker Regeneron, have mainly been used to treat people who are already infected with the coronavirus.

“To slow the ongoing loss of animal and plant life in the United States, President Biden signed an executive order in January 2,021 stating his administration’s goal to conserve 30% of U.S. lands and water by 2030. This bold, science-based initiative – America the Beautiful – is the first ever nationwide conservation effort to address both climate change and biodiversity loss.” https://www.futuretimeline.net/images/robot-future-timeline.jpg

The U.S. Fish and Wildlife Service (USFWS) has declared 23 species extinct, due to a combination of development, invasive species, logging and pollution.

The agency is recommending that the species be removed from the Endangered Species Act (ESA), the primary law in the United States for protecting and recovering imperilled organisms and the ecosystems they depend on. For the animals proposed for delisting, the protections of the ESA came too late.

Continue reading “23 species declared extinct in the U.S.” »

Comprehensive health, social services and economic well-being for american indian and alaska native elders — larry curley, executive director, national indian council on aging.

Mr. Larry Curley is Executive Director of The National Indian Council on Aging (https://www.nicoa.org/), a 501©(3) nonprofit organization founded in 1976 by members of the National Tribal Chairmen’s Association who called for a national organization focused on the needs of aging American Indian and Alaska Native elders. The mission of NICOA is to advocate for improved comprehensive health, social services and economic well-being for American Indian and Alaska Native elders.

Continue reading “Larry Curley — Executive Director — The National Indian Council on Aging (NICOA)” »

Diagnosing, Treating, And Preventing Neglected Tropical Diseases — Dr. Maria Elena Bottazzi, BCM National School of Tropical Medicine, Baylor University.

Dr. Maria Elena Bottazzi (https://www.bcm.edu/people-search/maria-bottazzi-18431) is Distinguished Professor of Biology, Associate Dean of the National School of Tropical Medicine, and Professor in the Departments of Pediatrics, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, and Translational Biology and Molecular Medicine, at Baylor College of Medicine.

Continue reading “Dr. Maria Elena Bottazzi — National School of Tropical Medicine — Baylor College of Medicine” »

Your DNA is in a database.

Your genetic code is probably already in a database, without you ever giving a sample or permission. This video is sponsored by Brilliant. The first 200 people to sign up via https://brilliant.org/veritasium get 20% off a yearly subscription.

Continue reading “Catching Criminals With Their Relative’s DNA” »

Sickle-cell disease is incurable and affects 15,000 people in the UK.

And the National Institute for Health and Care Excellence said the hope of reducing health inequalities for black people, who are predominantly affected and often have poorer health to start with, made the drug worth recommending.

It called it “an innovative treatment”.

Continue reading “First new treatment for sickle cell in 20 years” »

Enterprises of all sizes and across virtually all markets are scrambling to augment their analytics capabilities with artificial intelligence (AI) in the hopes of gaining a competitive advantage in a challenging post-pandemic economy.

Plenty of anecdotal evidence points to AI’s ability to improve analytics, but there seems to be less conversation around how it should be implemented in production environments, let alone how organizations should view it strategically over the long term.

I think so.

A recent study demonstrates that machine learning methods could determine the risk of a viral jump or “spillover” from animals to humans.

Continue reading “Can AI help predict the next pandemic?” »

Gene editing works at low efficiency in dogs.